PrEP drug reduces risk of HIV by 90%'

SOWETO, SOUTH AFRICA NOVEMBER 30:(SOUTH AFRICA OUT): Thembelani Sibanda shows the Pre-Exposure Prophylaxis (PrEP), an HIV preventative drug during an interview on November 30, 2017 in Soweto, South Africa. Sibanda, who is not HIV-positive, takes a preventative drug due to his lifestyle that he feels puts him at risk of contracting the virus. (Photo by Daniel Born/The Times/Gallo Images/Getty Images)
SOWETO, SOUTH AFRICA NOVEMBER 30:(SOUTH AFRICA OUT): Thembelani Sibanda shows the Pre-Exposure Prophylaxis (PrEP), an HIV preventative drug during an interview on November 30, 2017 in Soweto, South Africa. Sibanda, who is not HIV-positive, takes a preventative drug due to his lifestyle that he feels puts him at risk of contracting the virus. (Photo by Daniel Born/The Times/Gallo Images/Getty Images)
PrEP drug reduces risk of HIV by 90%'
COMPRAR UMA LICENÇA
Como posso usar esta imagem?
R$ 3.000,00
BRL

DETALHES

Restrições:
Contate o escritório local para todos os usos comerciais ou promocionais.SOUTH AFRICA OUT
Crédito:
The Times / Colaborador
ID Editorial:
888296568
Coleção:
Gallo Images
Data da criação:
01 de dezembro de 2017
Data do upload:
Tipo de licença:
Direitos controlados
Info sobre autorização:
Sem autorização Mais informações
Fonte:
Gallo Images Editorial
Nome do objeto:
AV_00070642
Tamanho máximo do arquivo:
3543 x 2362 px (30,00 x 20,00 cm) - 300 dpi - 3 MB